Sprott Report, page-35

Well that's an interesting way of looking at it, dialing in the performance of the EMR share subsequent to the paying of 30c per bullzeye share, to get to 64c a share.

Anyone that held the EMR shares that they acquired has achieved that combined return, and it has worked out well, but those that took the 30c per share offer ended up in a company that only owned 60% of bullzeye and had multiple supreme court cases with major shareholders on-going with no clear end to them. The fact that the EMR SP has done well in the intervening year + has worked in their favour.

Those getting 55.5c per share (based on todays $2.20 SP) are doing so knowing that EMR will likely have 100% ownership of a completely litigation free Bullzeye. It is a far more assured position. Also worth noting that those that took part in the recent two 5% fundraises, In December last year and March of this year, acquired an additional 10% of their holding at 29c, which are now worth 55.5c (based on $2.20 SP).